Theravance Biopharma Inc. (TBPH) gained 7.2% or 1.77 to $26.43. It is nearly 311656 shares traded, which is 142.49% compare to the average total volume 218725. The market cap of TBPH is $1.45 billion. The year to date change is -4.95%. The 52 week price range is from $21.27 to $42.61. Price of TBPH have changed 7.69% during last week. It have changed 3.18% over last month, 1.77% over last 3 months, -8.90% over last 6 months and -40.48% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for TBPH is 23.95. It is -9.38% below current price. The 200-day Moving Averages for TBPH is 27.23. It is 3.03% above current price. The 52-week High is 42.61. It is 61.22% from the current price. The 52-week Low is 21.27. It is -19.52% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of TBPH is 28.86 on 2018-06-15. Short % to float is 12.75%. There are some statistics of TBPH. It is has market cap $1.45 billion. The share outstanding is 54.85 million. The average volume is 218725. The revenue is 7.78M. The gross profit is 5.44M. The percent of top 15 Institution holding is 81.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of TBPH is -141.32%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of TBPH is -49.14%.